Neuroimaging in multiple sclerosis.

[1]  G. Barker,et al.  Correlation of magnetization transfer ration with clinical disability in multiple sclerosis , 1994, Annals of neurology.

[2]  R. Beck,et al.  The effect of corticosteroids for acute optic neuritis on the subsequent development of multiple sclerosis. The Optic Neuritis Study Group. , 1993, The New England journal of medicine.

[3]  A. Thompson,et al.  Spinal cord MRI using multi‐array coils and fast spin echo , 1993, Neurology.

[4]  J. Taubenberger,et al.  Correlation between magnetic resonance imaging findings and lesion development in chronic, active multiple sclerosis , 1993, Annals of neurology.

[5]  F. Fazekas,et al.  Pathologic correlates of incidental MRI white matter signal hyperintensities , 1993, Neurology.

[6]  A. Detsky,et al.  The Accuracy of Magnetic Resonance Imaging in Patients With Suspected Multiple Sclerosis , 1993 .

[7]  H. McFarland,et al.  Clinical worsening in multiple sclerosis is associated with increased frequency and area of gadopentetate dimeglumine–enhancing magnetic resonance imaging lesions , 1993, Annals of neurology.

[8]  F. Fazekas,et al.  Assessment of MRI criteria for a diagnosis of MS , 1993, Neurology.

[9]  G. Barker,et al.  Detection of myelin breakdown products by proton magnetic resonance spectroscopy , 1993, The Lancet.

[10]  D. Paty,et al.  Magnetic resonance spectroscopy of multiple sclerosis: in-vivo detection of myelin breakdown products , 1993, The Lancet.

[11]  J. Hajnal,et al.  Magnetic resonance imaging of spinal cord in multiple sclerosis by fluid-attenuated inversion recovery , 1993, The Lancet.

[12]  D. Paty,et al.  A population‐based study of multiple sclerosis in twins: Update , 1993 .

[13]  A. Czeizel,et al.  Environmental trichlorfon and cluster of congenital abnormalities , 1993, The Lancet.

[14]  D. Miller,et al.  The significance of brain magnetic resonance imaging abnormalities at presentation with clinically isolated syndromes suggestive of multiple sclerosis. A 5-year follow-up study. , 1993, Brain : a journal of neurology.

[15]  Roland Martin,et al.  Using gadolinium‐enhanced magnetic resonance imaging lesions to monitor disease activity in multiple sclerosis , 1992, Annals of neurology.

[16]  J. Hajnal,et al.  Use of Fluid‐Attenuated Inversion‐Recovery Pulse Sequences for Imaging the Spinal Cord , 1992, Magnetic resonance in medicine.

[17]  S. Karlik,et al.  Serial cranial and spinal cord magnetic resonance imaging in multiple sclerosis , 1992, Annals of neurology.

[18]  O. Salonen,et al.  Familial multiple sclerosis: MRI findings in clinically affected and unaffected siblings. , 1992, Journal of neurology, neurosurgery, and psychiatry.

[19]  D. Louis Collins,et al.  Model-based 3-D segmentation of multiple sclerosis lesions in dual-echo MRI data , 1992, Other Conferences.

[20]  W. Mcdonald,et al.  Occurrence of a multiple sclerosis-like illness in women who have a Leber's hereditary optic neuropathy mitochondrial DNA mutation. , 1992, Brain : a journal of neurology.

[21]  Alan C. Evans,et al.  Anatomical mapping of functional activation in stereotactic coordinate space , 1992, NeuroImage.

[22]  R. Capra,et al.  Gadolinium-pentetic acid magnetic resonance imaging in patients with relapsing remitting multiple sclerosis. , 1992, Archives of neurology.

[23]  P M Matthews,et al.  Proton magnetic resonance spectroscopic imaging for metabolic characterization of demyelinating plaques , 1992, Annals of neurology.

[24]  R I Grossman,et al.  Experimental allergic encephalomyelitis and multiple sclerosis: lesion characterization with magnetization transfer imaging. , 1992, Radiology.

[25]  A. Thompson,et al.  Serial gadolinium‐enhanced MRI in relapsing/remitting multiple sclerosis of varying disease duration , 1992, Neurology.

[26]  B. Ford,et al.  Long‐term follow‐up of acute partial transverse myelopathy , 1992, Neurology.

[27]  F. Barkhof,et al.  A correlative triad of gadolinium‐DTPA MRI, EDSS, and CSF‐MBP in relapsing multiple sclerosis patients treated with high‐dose intravenous methylprednisolone , 1992, Neurology.

[28]  B E Kendall,et al.  The pathophysiology of acute optic neuritis. An association of gadolinium leakage with clinical and electrophysiological deficits. , 1991, Brain : a journal of neurology.

[29]  P. Scheltens,et al.  Quantitative MRI changes in gadolinium‐DTPA enhancement after high‐dose intravenous methylprednisolone in multiple sclerosis , 1991, Neurology.

[30]  P M Matthews,et al.  Proton magnetic resonance spectroscopy for metabolic characterization of plaques in multiple sclerosis , 1991, Neurology.

[31]  S. Wray,et al.  Uhthoff's symptom in optic neuritis: Relationship to magnetic resonance imaging and development of multiple sclerosis , 1991, Annals of neurology.

[32]  A. Thompson,et al.  Magnetic resonance imaging in monitoring the treatment of multiple sclerosis: concerted action guidelines. , 1991, Journal of neurology, neurosurgery, and psychiatry.

[33]  N. Patronas,et al.  Serial gadolinium‐enhanced magnetic resonance imaging scans in patients with early, relapsing‐remitting multiple sclerosis: Implications for clinical trials and natural history , 1991, Annals of neurology.

[34]  D. Li,et al.  Magnetic resonance imaging of the head in the diagnosis of multiple sclerosis: A prospective 2‐year follow‐up with comparison of clinical evaluation, evoked potentials, oligoclonal banding, and CT , 1991, Neurology.

[35]  W. Mcdonald,et al.  Patterns of blood-brain barrier breakdown in inflammatory demyelination. , 1991, Brain : a journal of neurology.

[36]  E P du Boulay,et al.  Histopathology of multiple sclerosis lesions detected by magnetic resonance imaging in unfixed postmortem central nervous system tissue. , 1991, Brain : a journal of neurology.

[37]  E. Thompson,et al.  The predictive value of intrathecal immunoglobulin synthesis and magnetic resonance imaging in acute isolated syndromes for subsequent development of multiple sclerosis , 1991, Annals of neurology.

[38]  A. Thompson,et al.  Major differences in the dynamics of primary and secondary progressive multiple sclerosis , 1991, Annals of neurology.

[39]  F. Munschauer,et al.  Clinical and magnetic resonance imaging in optic neuritis , 1991, Neurology.

[40]  B E Kendall,et al.  Breakdown of the blood-brain barrier precedes symptoms and other MRI signs of new lesions in multiple sclerosis. Pathogenetic and clinical implications. , 1990, Brain : a journal of neurology.

[41]  W. Smoker,et al.  MRI in familial multiple sclerosis , 1990, Neurology.

[42]  I. Moseley,et al.  Acute disseminated encephalomyelitis , 2016, Neurology.

[43]  P M Matthews,et al.  Proton magnetic resonance spectroscopy of human brain in vivo in the evaluation of multiple sclerosis: Assessment of the load of disease , 1990, Magnetic resonance in medicine.

[44]  A. Thompson,et al.  Patterns of disease activity in multiple sclerosis: clinical and magnetic resonance imaging study. , 1990, BMJ.

[45]  A J Petkau,et al.  Systemic lymphoblastoid interferon therapy in chronic progressive multiple Sclerosis. I. Clinical and MRI evaluation , 1990, Neurology.

[46]  J. Talairach,et al.  Co-Planar Stereotaxic Atlas of the Human Brain: 3-Dimensional Proportional System: An Approach to Cerebral Imaging , 1988 .

[47]  W. Mcdonald,et al.  Lessons from magnetic resonance imaging in multiple sclerosis , 1989, Trends in Neurosciences.

[48]  E. Merelli,et al.  Diagnostic investigations in MS: which is the most sensitive? , 1989, Acta neurologica Scandinavica.

[49]  J. Olesen,et al.  Assessment of demyelination, edema, and gliosis by in vivo determination of T1 and T2 in the brain of patients with acute attack of multiple sclerosis , 1989, Magnetic resonance in medicine.

[50]  G Johnson,et al.  Precise relaxation time measurements of normal‐appearing white matter in inflammatory central nervous system disease , 1989, Magnetic resonance in medicine.

[51]  M. Newton,et al.  Tropical spastic paraparesis and human T cell lymphotropic virus type 1 in the United Kingdom. , 1989, Brain : a journal of neurology.

[52]  P. Duray,et al.  Central nervous system manifestations of Lyme disease. , 1989, Archives of neurology.

[53]  R. Balaban,et al.  Magnetization transfer contrast (MTC) and tissue water proton relaxation in vivo , 1989, Magnetic resonance in medicine.

[54]  M. Norenberg,et al.  Multiple sclerosis‐like illness occurring with human immunodeficiency virus infection , 1989, Neurology.

[55]  D. Li,et al.  Serial magnetic resonance scanning in multiple sclerosis: A second prospective study in relapsing patients , 1989, Annals of neurology.

[56]  D. Li,et al.  Benign versus chronic progressive multiple sclerosis: Magnetic resonance imaging features , 1989, Annals of neurology.

[57]  G. Johnson,et al.  Quantitative magnetic resonance imaging in multiple sclerosis: the effect of high dose intravenous methylprednisolone. , 1989, Journal of neurology, neurosurgery, and psychiatry.

[58]  B E Kendall,et al.  The early risk of multiple sclerosis after optic neuritis. , 1988, Journal of neurology, neurosurgery, and psychiatry.

[59]  H Lechner,et al.  Criteria for an increased specificity of MRI interpretation in elderly subjects with suspected multiple sclerosis , 1988, Neurology.

[60]  J. Oger,et al.  Multiple sclerosis , 1988, Neurology.

[61]  O. Selnes,et al.  Magnetic resonance imaging of cerebral lesions in patients with the Sjögren syndrome. , 1988, Annals of internal medicine.

[62]  D. MacManus,et al.  Magnetic resonance imaging in central nervous system sarcoidosis , 1988, Neurology.

[63]  B E Kendall,et al.  Magnetic resonance imaging of the optic nerve in optic neuritis , 1988, Neurology.

[64]  D. N. Landon,et al.  The characterization of experimental gliosis by quantitative nuclear magnetic resonance imaging. , 1988, Brain : a journal of neurology.

[65]  A. A. Eisen,et al.  MRI in the diagnosis of MS , 1988, Neurology.

[66]  R. Schmidt,et al.  Nuclear magnetic resonance image white matter lesions and risk factors for stroke in normal individuals. , 1988, Stroke.

[67]  P. Sandercock,et al.  Magnetic resonance imaging in isolated noncompressive spinal cord syndromes , 1987, Annals of neurology.

[68]  B E Kendall,et al.  The role of NMR imaging in the assessment of multiple sclerosis and isolated neurological lesions. A quantitative study. , 1987, Brain : a journal of neurology.

[69]  D. Paty,et al.  A population-based study of multiple sclerosis in twins. , 1986, The New England journal of medicine.

[70]  M. Aminoff,et al.  Evaluation of patients with multiple sclerosis by evoked potentials and magnetic resonance imaging: A comparative study , 1986, Annals of neurology.

[71]  R. Kakigi,et al.  Disseminated lesions at presentation in patients with optic neuritis. , 1986, Journal of neurology, neurosurgery, and psychiatry.

[72]  M Brant-Zawadzki,et al.  MR imaging of the aging brain: patchy white-matter lesions and dementia. , 1985, AJNR. American journal of neuroradiology.

[73]  S. Gilman,et al.  The initial diagnosis of multiple sclerosis: Clinical impact of magnetic resonance imaging , 1985, Annals of neurology.

[74]  R. Martínez,et al.  Traumatic birth and syringomyelia , 1985, Neurology.

[75]  D. Paty,et al.  CORRELATION BETWEEN NMR SCAN AND BRAIN SLICE DATA IN MULTIPLE SCLEROSIS , 1984, The Lancet.

[76]  B. Bass,et al.  Mulocal CT enhancement in MS , 1984, Neurology.

[77]  L. Kaufman,et al.  Nuclear magnetic resonance imaging in multiple sclerosis , 1983, Annals of neurology.

[78]  D. Silberberg,et al.  New diagnostic criteria for multiple sclerosis: Guidelines for research protocols , 1983, Annals of neurology.

[79]  A. S. Hall,et al.  NUCLEAR MAGNETIC RESONANCE IMAGING OF THE BRAIN IN MULTIPLE SCLEROSIS , 1981, The Lancet.

[80]  M. Alter,et al.  Acute transverse myelitis , 1981, Neurology.

[81]  A. Ropper,et al.  The prognosis of acute and subacute transverse myelopathy based on early signs and symptoms , 1978, Annals of neurology.

[82]  H. Lipton,et al.  Acute transverse myelopathy in adults. A follow-up study. , 1973, Archives of neurology.

[83]  P. Altrocchi.  ACUTE TRANSVERSE MYELOPATHY. , 1963, Archives of neurology.